<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ford AL</submitter><funding>NCATS NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NIAMS NIH HHS</funding><pagination>e1918-e1931</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7682842</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>95(14)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To characterize lesion evolution and neurodegeneration in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) using multimodal MRI.&lt;h4>Methods&lt;/h4>We prospectively performed MRI and cognitive testing in RVCL-S and healthy control cohorts. Gray and white matter volume and disruption of white matter microstructure were quantified. Asymmetric spin echo acquisition permitted voxel-wise oxygen extraction fraction (OEF) calculation as an in vivo marker of microvascular ischemia. The RVCL-S cohort was included in a longitudinal analysis of lesion subtypes in which hyperintense lesions on fluid-attenuated inversion recovery (FLAIR), T1-postgadolinium, and diffusion-weighted imaging were delineated and quantified volumetrically.&lt;h4>Results&lt;/</pubmed_abstract><journal>Neurology</journal><pubmed_title>Lesion evolution and neurodegeneration in RVCL-S: A monogenic microvasculopathy.</pubmed_title><pmcid>PMC7682842</pmcid><funding_grant_id>R01 AI143982</funding_grant_id><funding_grant_id>R01 HL129241</funding_grant_id><funding_grant_id>UL1 TR002345</funding_grant_id><funding_grant_id>K08 AR070918</funding_grant_id><funding_grant_id>UL1 TR000448</funding_grant_id><pubmed_authors>Balasetti V</pubmed_authors><pubmed_authors>Miner JJ</pubmed_authors><pubmed_authors>Ford AL</pubmed_authors><pubmed_authors>Chin VW</pubmed_authors><pubmed_authors>Hassenstab J</pubmed_authors><pubmed_authors>Binkley MM</pubmed_authors><pubmed_authors>An H</pubmed_authors><pubmed_authors>Fellah S</pubmed_authors><pubmed_authors>Jen JC</pubmed_authors><pubmed_authors>Bodin AM</pubmed_authors><pubmed_authors>Liszewski MK</pubmed_authors><pubmed_authors>Bogacki M</pubmed_authors><pubmed_authors>Lin D</pubmed_authors><pubmed_authors>Grand MG</pubmed_authors><pubmed_authors>Atkinson JP</pubmed_authors><pubmed_authors>Kang P</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Lee JM</pubmed_authors><pubmed_authors>Taiwo Y</pubmed_authors><pubmed_authors>Hourcade D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lesion evolution and neurodegeneration in RVCL-S: A monogenic microvasculopathy.</name><description>&lt;h4>Objective&lt;/h4>To characterize lesion evolution and neurodegeneration in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) using multimodal MRI.&lt;h4>Methods&lt;/h4>We prospectively performed MRI and cognitive testing in RVCL-S and healthy control cohorts. Gray and white matter volume and disruption of white matter microstructure were quantified. Asymmetric spin echo acquisition permitted voxel-wise oxygen extraction fraction (OEF) calculation as an in vivo marker of microvascular ischemia. The RVCL-S cohort was included in a longitudinal analysis of lesion subtypes in which hyperintense lesions on fluid-attenuated inversion recovery (FLAIR), T1-postgadolinium, and diffusion-weighted imaging were delineated and quantified volumetrically.&lt;h4>Results&lt;/</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Oct</publication><modification>2025-04-04T10:55:28.031Z</modification><creation>2021-02-21T06:30:25Z</creation></dates><accession>S-EPMC7682842</accession><cross_references><pubmed>32887784</pubmed><doi>10.1212/WNL.0000000000010659</doi></cross_references></HashMap>